Strumento inattivo

Azioni Baxalta Inc

Azioni

Prezzo di chiusura Nyse Altri mercati azionari
- ^USD	-

Baxalta : Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions	03/06/16
Baxalta : CORRECTING and REPLACING Baxalta Shareholders Vote to Approve Combination	27/05/16
Baxalta : OncoResponse Secures Investment from Baxalta	26/05/16
Baxalta : Reports Positive Phase 1 Results for BAX 930, Investigational Recombinant ADAMTS13 to Treat Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)	25/05/16
Baxalta : Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc.	25/05/16

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,37%	86,85 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	40,16 Mrd
BIOGEN INC.	-16,48%	31,28 Mrd
UCB	+57,86%	25,27 Mrd
BIOMARIN PHARMACEUTICAL INC.	-13,58%	15,33 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	11,96 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,61 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+6,89%	8,83 Mrd
INNOVENT BIOLOGICS, INC.	-10,53%	7,94 Mrd